REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY: A Multicenter Study.

Authors :: Cernichiaro-Espinosa LA
Harper CA 3rd
Read SP
Wright LM
Scribbick FW 3rd
Young R
Negron CI
Rodríguez A
Berrocal AM
Source :: Retina (Philadelphia, Pa.) [Retina] 2018 Jun; Vol. 38 (6), pp. 1251-1255.
Publication Year :: 2018

Subjects :: Humans
Infant, Newborn
Intravitreal Injections adverse effects
Vascular Endothelial Growth Factor A antagonists & inhibitors
Angiogenesis Inhibitors administration & dosage
Bevacizumab administration & dosage
Intravitreal Injections instrumentation
Ranibizumab administration & dosage
Retinopathy of Prematurity drug therapy

Full Text Access

Tools